Sartorius introduces the new iQue ®, a High-Throughput Screening (HTS) by Cytometry platform that is designed to focus on speed from installation to acquisition and analysis. It can deliver actionable ...

SAN ANTONIO, May 27, 2026--bioAffinity Technologies receives notice of allowance for Mexican patent on methods of predicting the likelihood of lung cancer using flow cytometry.

Researchers found that the cancer-driving protein MYC helps tumors repair DNA damage and survive treatment. The discovery could lead to new ways to weaken cancers by shutting down one of their key ...

Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, has introduced the next generation XR-Series, a ...

The newly integrated University of Texas at San Antonio and its academic health center, UT Health San Antonio, recently received over $2.7 million from the Cancer Prevention and Research Institute of ...

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.

Primary central nervous system (CNS) malignancies present unique therapeutic challenges due to their complex biology, immunosuppressive microenvironment, ...

Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced ...

Chikungunya virus, which is transmitted to people by infected Aedes mosquitoes and characterized by high fever and intense joint swelling and pain, has made a resurgence in many countries around the ...

FT836 demonstrates meaningful reduction in target lesions without the use of conditioning chemotherapy in metastatic colorectal cancerDetection ...